20.10.2026

Meet Alithea Bio at World Vaccine Congress Europe 2026

World of Vaccine Congress Alithea Bio

Alithea Bio at World Vaccine Congress Europe 2026, RAI Amsterdam

Alithea Bio is attending World Vaccine Congress Europe at the RAI Convention Centre in Amsterdam on 20–21 October 2026. If you’re working on vaccine target discovery, we’d love to meet you and talk about what immunopeptidomics can add to your program.

Book a Meeting With Us →

Event Details

Alithea Bio logo
World Vaccine Congress Europe logo
  • Event: World Vaccine Congress Europe 2026
  • Venue: RAI Convention Centre, Amsterdam
  • Conference: Tuesday 20 October, 09:00–17:45, and Wednesday 21 October, 09:00–16:45
  • Exhibition: Tuesday 20 October, 08:00–18:00, and Wednesday 21 October, 08:00–17:00
  • Where to find us: Booth 553

Why We’re at World Vaccine Congress

Vaccine development, from infectious disease to cancer vaccines, depends on choosing the right targets. Many of those targets are peptides that must be presented on HLA molecules to be seen by the immune system. Computational prediction can suggest which peptides might be presented, but mass-spectrometry-based immunopeptidomics shows which ones actually are.

That evidence is what we bring to the congress: a way to move from predicted targets to observed ones, and to check early where else in the body a candidate is presented.

What to Talk to Us About

  • HLA-Compass: our immunopeptidomics database of HLA-presented peptides across thousands of real-world samples.
  • Tumor-specific target discovery: including peptides from the dark proteome, the subject of our recent feature in Nature Biotechnology.
  • Target safety: healthy-tissue profiling to understand where a candidate peptide is also presented.
  • Collaboration: how our team can support your vaccine or immunotherapy program.
Discover Our Dark Proteome Work →

Frequently Asked Questions

Where can I find Alithea Bio at the event?

We’ll be at Booth 553 at the RAI Convention Centre during exhibition hours on both days. You can also book a time in advance using the button above.

What is immunopeptidomics?

Immunopeptidomics is the mass-spectrometry-based analysis of the peptides presented on HLA molecules at the cell surface. These peptides are what the immune system actually sees, which makes them directly relevant for vaccine and immunotherapy target selection.

Who should meet with us?

Teams working on cancer vaccines, neoantigen-based approaches, or any program where knowing which peptides are truly presented on HLA would sharpen target selection.

Connect with Alithea Bio

Can’t make it to Amsterdam? We’re happy to connect afterwards.

Discover HLA-Compass →

Related reading: Dark Proteome Unlocked: HLA-Compass AI Finds 17,082 Cancer Targets | Neoantigens | Immunopeptidomics Technology

@media (max-width: 600px) { .blog-post h1 { font-size: 26px !important; line-height: 1.3 !important; } .blog-post h2 { font-size: 20px !important; } .blog-post p, .blog-post li { font-size: 16px !important; line-height: 1.6 !important; } .blog-post a[style*="background-color:#1a1a1a"] { display:block !important; width: 100% !important; box-sizing: border-box; } }

Read more

Alithea Bio

Alithea Bio Featured in Nature Biotechnology’s Dark Proteome Report

Read
CFO FANNY GIANNOU AND CSO DR. TIM FUGGMAN, ALITHEA BIO

Can this AI predict the side effects of cancer therapies before the first human dose?

Read
Alithea Bio summer Stories

Alithea Bio Summer Stories, Get every story in full!

Read